HEATHER KRAMER: Open Payments
NPI 1053648162 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$167 in 6 payments from 6 companies in 2025. Trend: 2023 $601 · 2024 $101 · 2025 $167
Food & beverage: $167
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 1 | $53 |
| Myriad Genetic Laboratories, Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Celgene Corporation | 1 | $23 |
| Alexion Pharmaceuticals, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: MYRISK, DATROWAY, REBLOZYL, ULTOMIRIS, SCEMBLIX.
Industry payments across NY — which companies pay providers there.
